Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Charles River Laboratories International Inc. (CRL)

128.71 -2.48 (-1.89%)

11-14 16:02

Open:

132.31

Pre. Close:

131.19

High:

133.385

Low:

128.18

Volume:

417,361

Market Cap:

6190M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

133.527 - 134.614

134.614 - 135.345

Low:

125.968 - 127.15

127.15 - 127.943

Close:

127.13 - 128.952

128.952 - 130.175

Technical analysis  (as of: 2018-11-14 4:31:24 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 162.22     One year: 189.48

Support:

Support1: 122.88    Support2: 112.98

Resistance:

Resistance1: 138.89    Resistance2: 162.22

Pivot:

126.23

Moving Averages:

MA(5): 133.22     MA(20): 124.94

MA(100): 123.82     MA(250): 113.91

MACD:

MACD(12,26): 1.97     Signal(12,26,9): 0.86

%K %D:

%K(14,3): 69.54     %D(3): 78.80

RSI:

RSI(14): 52.73

52-Week:

High: 138.89  Low: 96.7  Change(%): 26.8

Average Vol(K):

3-Month: 39228  10-Days 42178

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
CRL has closed below upper band by 41.0%. Bollinger Bands are 124% wider than normal. The large width of the bands suggest high volatility as compared to CRL's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

2018-11-13T08:00:00-05:00
Charles River Laboratories Continues Commitment to Oncology Drug Discovery

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Diagnostics Research

Shares Out. (M)

48.10

Shares Float (M)

46.27

% Held by Insiders

3.80

% Held by Institutions

63.00

Shares Short (K)

1082

Shares Short Prior Month (K)

Stock Financials

EPS

5.930

EPS Est. Current Year

5.100

EPS Est. Next Year

5.610

EPS Est. Next Quarter

1.300

Forward EPS

6.571

Book Value (p.s.)

5.220

PEG Ratio

1.86

Profit Margin

6.51

Operating Margin

16.12

Return on Assets (ttm)

4.1

Return on Equity (ttm)

12.0

Qtrly Rev. Growth

24.8

Gross Profit (p.s.)

3.488

Sales Per Share

EBITDA (p.s.)

2.292

Qtrly Earnings Growth

-0.50

Operating Cash Flow (M)

363.10

Levered Free Cash Flow (M)

258.04

Valuation

P/E

21.70

P/E Growth Ratio

-0.02

P/BV

24.65

P/S

145755184.00

P/CF

17.04

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.